Log in

Pacira BioSciences Price Target, Predictions & Analyst Ratings

+1.16 (+2.14 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $55.47
50-Day Range
MA: $58.61
52-Week Range
Now: $55.47
Volume248,000 shs
Average Volume637,653 shs
Market Capitalization$2.37 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Pacira BioSciences (NASDAQ:PCRX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
14 Wall Street analysts have issued ratings and price targets for Pacira BioSciences in the last 12 months. Their average twelve-month price target is $62.50, predicting that the stock has a possible upside of 12.67%. The high price target for PCRX is $85.00 and the low price target for PCRX is $41.00. There are currently 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
PCRX Consensus Rating: BuyBuyBuyBuy
PCRX Consensus Rating Score: 2.792.792.672.73
PCRX Analyst Ratings: 0 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
PCRX Consensus Price Target: $62.50$62.07$59.14$53.67
PCRX Price Target Upside: 12.67% upside19.35% upside21.79% upside29.99% upside

Pacira BioSciences (NASDAQ:PCRX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Pacira BioSciences (NASDAQ:PCRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/7/2020WedbushReiterated RatingBuy$85.00Medium
9/30/2020Jefferies Financial GroupBoost Price Target$69.00 ➝ $75.00Low
9/21/2020Northland SecuritiesUpgradeMarket Perform ➝ Outperform$58.00 ➝ $67.00Medium
9/9/2020Needham & Company LLCBoost Price TargetBuy$64.00 ➝ $68.00High
8/14/2020TruistBoost Price Target$54.00 ➝ $65.00Low
8/10/2020HC WainwrightBoost Price TargetBuy$68.00 ➝ $70.00High
7/6/2020Piper SandlerBoost Price TargetPositive ➝ Overweight$49.00 ➝ $65.00Medium
7/1/2020Royal Bank of CanadaBoost Price TargetOutperform$56.00 ➝ $62.00High
6/30/2020SVB LeerinkBoost Price TargetOutperform$45.00 ➝ $58.00Medium
5/26/2020GuggenheimInitiated CoverageNeutralLow
5/7/2020Stifel NicolausLower Price TargetHold$49.00 ➝ $48.00Low
1/23/2020SunTrust BanksInitiated CoverageBuy$60.00Low
11/8/2019BarclaysBoost Price TargetOverweight$52.00 ➝ $55.00Medium
11/7/2019CowenReiterated RatingHold$41.00High
11/6/2019BTIG ResearchInitiated CoverageBuy$56.00 ➝ $56.00Medium
8/9/2019BMO Capital MarketsLower Price TargetMarket Perform$46.00 ➝ $43.00Low
5/6/2019MizuhoUpgradeUnderperform ➝ Neutral$29.00 ➝ $38.00Low
4/9/2019Piper Jaffray CompaniesSet Price TargetBuy$55.00Low
2/12/2019National SecuritiesInitiated CoverageSellMedium
11/2/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$45.00 ➝ $50.00Low
11/1/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Buy$56.00 ➝ $63.00High
10/10/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$46.00 ➝ $48.00High
10/2/2018Canaccord GenuitySet Price TargetHold ➝ Hold$45.00 ➝ $49.00Low
5/17/2018OppenheimerReiterated RatingHoldLow
4/8/2018Seaport Global SecuritiesSet Price TargetBuy$48.00Medium
11/16/2017Janney Montgomery ScottSet Price TargetSell$27.00N/A
(Data available from 10/26/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.